SINOPHARM released its first-quarter performance, with a net profit attributable to the parent company of 459 million yuan, a year-on-year decrease of 0.1%
I'm PortAI, I can summarize articles.
According to the Zhitong Finance APP, SINOPHARM (CNCM LTD) released its first quarter report for 2025. The company's first quarter operating revenue was 12.713 billion yuan, a year-on-year increase of 4.87%; the net profit attributable to shareholders of the listed company was 459 million yuan, a year-on-year decrease of 0.10%; the net profit attributable to shareholders of the listed company after deducting non-recurring gains and losses was 446 million yuan, a year-on-year decrease of 2.57%; the basic earnings per share was 0.6084 yuan/share
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Zhitong The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments